Sonoma Pharmaceuticals (SNOA) EPS (Basic) Growth (3y) (2013 - 2025)
Sonoma Pharmaceuticals (SNOA) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 53.26% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.07% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.72% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -47.34% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 65.02% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -19.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -78.78% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 262.79% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -100.00% |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | 8.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.18% |
| Sep 30, 2025 | 1.02% |
| Jun 30, 2025 | -37.87% |
| Dec 31, 2024 | -26.67% |
| Sep 30, 2024 | -145.24% |
| Jun 30, 2024 | -37.10% |
| Mar 31, 2024 | 27.33% |
| Dec 31, 2023 | -72.46% |
| Sep 30, 2023 | -360.78% |
| Jun 30, 2023 | 9.40% |
| Mar 31, 2023 | 32.98% |
| Dec 31, 2022 | 4.86% |
| Sep 30, 2022 | 28.95% |
| Jun 30, 2022 | -36.39% |
| Dec 31, 2021 | 49.24% |
| Sep 30, 2021 | 78.33% |
| Jun 30, 2021 | 52.94% |
| Mar 31, 2021 | 59.78% |
| Dec 31, 2020 | 24.84% |
| Sep 30, 2020 | 27.85% |